Aventus Investment Advisors, Inc. Astrazeneca PLC Transaction History
Aventus Investment Advisors, Inc.
- $117 Billion
- Q3 2025
A detailed history of Aventus Investment Advisors, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Aventus Investment Advisors, Inc. holds 470 shares of AZN stock, worth $39,113. This represents 0.03% of its overall portfolio holdings.
Number of Shares
470
Previous 470
-0.0%
Holding current value
$39,113
Previous $32.8 Million
9.79%
% of portfolio
0.03%
Previous 0.03%
Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,442Shares Held
498MCall Options Held
7.22MPut Options Held
2.57M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.32 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.43 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.86 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.61 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.59 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $258B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...